Document

Meeting of the Advisory Committee on Blood Safety and Availability

Department of Health and Human Services AGENCY: Office of the Secretary. ACTION: Notice of Meeting. The Advisory Committee on Blood Safety and Availability will meet on Thursday...

Department of Health and Human Services

AGENCY:

Office of the Secretary.

ACTION:

Notice of Meeting.

The Advisory Committee on Blood Safety and Availability will meet on Thursday, January 25, 2001 and Friday, January 26, 2001, from 8:00 a.m. to 5:00 p.m.. The meeting will take place at the Hyatt Regency Hotel on Capitol Hill, 400 New Jersey Ave., NW., Washington, DC 20001. The meeting will be entirely open to the public.

The Advisory Committee will consider how the government should respond to the current public debate over universal leukoreduction.

Public comment will be solicited at the meeting. Public comment will be limited to five minutes per speaker. Those who wish to have printed material distributed to Advisory Committee members should submit thirty (30) copies to the Executive Secretary prior to close of business January 11, 2001.

FOR FURTHER INFORMATION CONTACT:

Stephen D. Nightingale, M.D., Executive Secretary, Advisory Committee on Blood Safety and Availability, Department of Health and Human Services, Office of Public Health and Science, 200 Independence Avenue, S.W., Rm 736E, Washington, D.C. 20201. Phone (202) 690-5560 FAX (202) 690-7560 e-mail .

Dated: October 6, 2000.

Stephen D. Nightingale,

Executive Secretary, Advisory Committee on Blood Safety and Availability.

[FR Doc. 00-26739 Filed 10-17-00; 8:45 am]

BILLING CODE 4160-17-M

Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

65 FR 62358

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“Meeting of the Advisory Committee on Blood Safety and Availability,” thefederalregister.org (October 18, 2000), https://thefederalregister.org/documents/00-26739/meeting-of-the-advisory-committee-on-blood-safety-and-availability.